Gilead Sciences
GILD
GILD
1,663 hedge funds and large institutions have $71.7B invested in Gilead Sciences in 2024 Q2 according to their latest regulatory filings, with 130 funds opening new positions, 643 increasing their positions, 680 reducing their positions, and 148 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,663
Holders Change
-42
Holders Change %
-2.46%
% of All Funds
24.19%
Holding in Top 10
13
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-7.14%
% of All Funds
0.19%
New
130
Increased
643
Reduced
680
Closed
148
Calls
$1.02B
Puts
$726M
Net Calls
+$291M
Net Calls Change
+$247M
Top Buyers
| 1 |
LA
1
LM Advisors
San Diego,
California
|
$550M |
| 2 |
2
Goldman Sachs
New York
|
$630M |
| 3 |
3
Wellington Management Group
Boston,
Massachusetts
|
$1.57B |
| 4 |
4
D.E. Shaw & Co
New York
|
$229M |
| 5 |
5
Millennium Management
New York
|
$174M |
Top Sellers
| 1 |
1
Capital World Investors
Los Angeles,
California
|
$5.23B |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$19.1M |
| 3 |
3
Nuveen Asset Management
Chicago,
Illinois
|
$342M |
| 4 |
4
Barclays
London,
United Kingdom
|
$319M |
| 5 |
5
BlackRock
New York
|
$8.28B |
